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Abstract
Background: Different generic quality of life instruments such as the Nottingham Health Profile
(NHP) and the Short Form 36 Health Survey (SF-36) have revealed conflicting results in patients
with chronic lower limb ischaemia in psychometric attributes in short-term evaluations. The aim of
this study was to compare the NHP and the SF-36 regarding internal consistency reliability, validity,
responsiveness and suitability as outcome measures in patients with lower limb ischaemia in a
longitudinal perspective.
Methods: 48 patients with intermittent claudication and 42 with critical ischaemia were included.
Assessment was made before and one year after revascularization using comparable domains of the
NHP and the SF-36 questionnaires.
Results: The SF-36 was less skewed and more homogeneous than the NHP. There was an average
convergent validity in three of the five comparable domains one year postoperatively. The SF-36
showed a higher internal consistency except for social functioning one-year postoperatively and
was more responsive in detecting changes over time in patients with intermittent claudication. The
NHP was more sensitive in discriminating among levels of ischaemia regarding pain and more able
to detect changes in the critical ischaemia group.
Conclusion:  Both SF-36 and NHP have acceptable degrees of reliability for group-level
comparisons, convergent and construct validity one year postoperatively. Nevertheless, the SF-36
has superior psychometric properties and was more suitable in patients with intermittent
claudication. The NHP however, discriminated better among severity of ischaemia and was more
responsive in patients with critical ischaemia.
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Background
During the past few decades quality of life assessment has
become one central outcome in treatment of patients with
chronic lower limb ischaemia. Different generic quality of
life instruments such as the Nottingham Health Profile
(NHP) and the Short Form 36 Health Survey (SF-36) [1,2]
have previously been tested, revealing conflicting results
in these patients according to psychometric attributes in
short-term evaluations. The strengths and weakness of the
NHP and the SF-36 scales are not extensively examined
and further research is needed to establish which is the
more appropriate and responsive quality of life instru-
ment for patients with chronic lower limb ischaemia in
the long term. The main goal of vascular surgical treat-
ment is the relief of symptoms and improvement in
patients quality of life. A majority of the patients are eld-
erly and have generally widespread arterial disease with
numbers of symptoms due to the chronic lower limb
ischaemia, which may affect the patients' quality of life [3-
5]. Intermittent claudication (IC) means leg pain con-
stantly produced by walking or muscular activity and is
relieved by rest, while critical leg ischaemia (CLI) means
pain even at rest and problems with non-healing ulcers or
gangrene [6]. It is important to identify dimensions which
are influenced by the severity and nature of the disease
when selecting a suitable quality of life instrument [7].
The World Health Organization QOL group [8] has iden-
tified and recommended five broad dimensions – physi-
cal and psychological health, social relationship
perceptions, function and well-being – which should be
included in a generic quality of life instrument. Generic
instruments cover a broad range of dimensions and allow
comparisons between different groups of patients. Dis-
ease-specific instruments, on the other hand, are specially
designed for a particular disease, patient group or areas of
function [9]. The functional scale, Walking Impairment
Questionnaire (WIQ) [10] and quality of life instruments
such as Intermittent Claudication Questionnaire (ICQ)
[11] and Claudication Scale (CLAU-S) [12] are examples
of disease-specific instruments which have been devel-
oped in recent years for patients with IC. However, at
present there is no accepted disease-specific questionnaire
for quality of life assessment in patients with CLI. Never-
theless, the TransAtlantic Inter-Society Consensus (TASC)
[6] recommended that quality of life instruments should
be used in all clinical trials and preferably include both
generic and disease-specific quality of life measures.
Outcome measures need to satisfy different criteria to be
useful as a suitable health outcome instrument in clinical
practice. Construct validity is one of the most important
characteristics and is a lengthy and ongoing process [13].
An essential consideration is the instrument's ability to
discriminate between different levels of the disease;
another consideration is its reliability, which means the
degree to which the instrument is free from random error
and all items measure the same underlying attribute [14].
Further, the requirement for a useful outcome measure is
the responsiveness in detecting small but important clini-
cal changes of quality of life in patients following vascular
interventions [13]. Finally the ideal quality of life instru-
ment must also be acceptable to patients, simple and easy
to use and preferably short. Comparisons among quality
of life instruments and their psychometric characteristics
and performance are needed to provide recommenda-
tions about their usefulness as outcome measures for
these particular groups of patients.
The aim of this study was to compare two generic quality
of life questionnaires, the Nottingham Health Profile
(NHP) and the Short Form 36 Health Survey (SF-36)
regarding the internal consistency reliability, validity,
responsiveness and suitability as outcome measures in
patients with lower limb ischaemia in a longitudinal
perspective.
Methods
Patients
Ninety consecutive patients from a Swedish vascular unit
in southern Sweden were invited to participate in this
study. The assessment took place before and 12 months
after revascularization. Out of 90 patients, 24 (27%)
dropped out during the follow-up period, of whom 14
suffered from CLI. Six patients (7%) died, 15 (17%) did
not wish to participate and 3 (3%) had other concurrent
diseases. The inclusion criteria were patients admitted for
active treatment of documented lower limb ischaemia,
having no communication problems and having no other
disease restricting their walking capacity [1]. The severity
of ischaemia was graded according to suggested standards
for grading lower limb ischaemia [15]. Sixty-two (68.8%)
patients were treated with a surgical bypass, 24 (26.6%)
had a percutaneous angioplasty (PTA) and 4 (4.6%) had
a surgical thromboendatherectomy (TEA) (Table 1). Rou-
tine medical history, risk factors and clinical examina-
tions, which included ankle blood pressure (ABP) and
ankle-brachial pressure index (ABPI), were obtained
before and one year after revascularization in accordance
with the Swedish Vascular Registry (Swedvasc) [16]. The
questionnaire also contains questions about sex, age,
housing and civil status. Demographic characteristics and
clinical data were obtained from the patients' medical
records.
Nottingham Health Profile
The Nottingham Health Profile (NHP) was developed to
be used in epidemiological studies of health and disease
[17]. It consists of two parts. Part I contains 38 yes/no
items in 6 dimensions: pain, physical mobility, emotionalHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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reactions, energy, social isolation and sleep. Part II con-
tains 7 general yes/no questions concerning daily living
problems. The two parts may be used independently and
part II is not analysed in this study. Part I is scored using
weighted values which give a range of possible scores from
zero (no problems at all) to 100 (presence of all problems
within a dimension). Swedish weights have been devel-
oped and used in this study [18]. The Swedish version has
proved to be valid and reliable, for example, in patients
with arthrosis of the hip joint [19] and in patients suffer-
ing from grave ventricular arrhythmias [20]. The NHP
scale has also proved capable of measuring changes in per-
ceived health following different treatments such as radi-
cal surgery for colorectal cancer [21] and after vascular
interventions in lower limb ischaemia patients [4,22,23].
Short Form 36 Health Survey
The Short Form 36 Health Survey (SF-36) was developed
by Ware et al [24] and designed to provide assessments
involving generic health concepts that are not specific to
age, disease or treatment group. It includes 36 items cov-
ering eight health concepts: bodily pain, physical func-
tioning, role limitations due to physical problems, mental
health, vitality, social functioning, role limitations due to
emotional problems and general health. The response for-
mat is yes or no or in a three-to-six response scale. For
each health concept questions scores are coded, summed
and transformed on a scale from zero (worst health) to
100 (best health). In this study, the standard Swedish ver-
sion was used [25]. The SF-36 has shown acceptable valid-
ity and reliability in population studies [26,27] and in
various groups of patients, for example after stroke [28]
and in patients with rheumatoid arthritis [29]. The SF-36
scale has also shown responsiveness to changes in health
Table 1: Demographic characteristics of the patient groups before revascularization (n = 90).
Claudicants n = 48 Critical ischaemia n = 42 P-value
Age m (SD)1 67 (10.2) 71 (10.1) .05
Sex %2 .52
Male/female 54/46 52/48
Cohabitation n (%)2 .33
Living alone 19 (39.6) 11 (26.2)
Living with family/relatives 29 (60.4) 31 (73.8)
Severity of disease n (%)
Intermittent claudication 48 (100)
Ischaemia rest pain 22 (52.2)
Ischaemia ulcers 17 (40.4)
Ischaemia gangrene 3 (7.4)
Type of intervention n (%)2 .02
Angioplasty/STENT 18 (37.5) 6 (14.3)
Bypass 28 (58.3) 34 (81.0)
Thromboendatherectomy 2 (4.2) 2 (4.8)
Level of disease n (%)
Iliac 22 (45.8) 13 (31.0)
Femoral (above knee) 20 (41.7) 10 (23.8)
Distal (below knee) 6 (12.5) 19 (45.2)
Leg side of disease n (%)
Unilateral 45 (93.7) 34 (81.0)
Bilateral 3 (6.3) 8 (19.0)
Risk factors n (%)2
Smoking 11 (22.9) 11 (26.2) .45
Hypertension 14 (29.2) 14 (33.3) .42
Heart disease 9 (18.8) 16 (38.1) .03
Diabetics 4 (10.4) 11 (26.2) .05
Hyperlipaemia 3 (6.3) 1 (2.4) .36
Stroke/TIA 4 (8.3) 2 (4.8) .40
Chronic lung disease 1 (2.1) 3 (7.1) .38
Kidney disease, kreat >150 2 (4.2) 2 (4.8) .64
*Reoperations during follow-
up n (%)
4 (6.1) 3 (4.5) .64
1Mann-Whitney U-test 2Chi-square test *Include the patients (n = 66) who completed the study one year postoperatively. P-value = <0.05Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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status over time in patients with critical ischaemia [30-32]
and in patients with intermittent claudication following a
revascularization [33-35].
Procedure
The patients were asked by the head nurse to fill out the
NHP and the SF-36 questionnaire during their admission
before treatment. At the one-year follow-up, the question-
naire was sent home to the patients with a covering letter
and a prepaid envelope. The Ethics Committee of Lund
University approved the study (LU 470-98, Gbg M 098-
98).
Statistical analysis
Differences in characteristics between patients with IC
and with CLI before revascularization were analysed using
Chi-squared test and Mann-Whitney U-test. The preva-
lence of the lowest ("floor" effect) and highest ("ceiling"
effect) possible quality of life score in NHP and SF-36 was
also calculated.
Construct validity was evaluated for aspects of convergent
and discriminant validity by the Multitrait-Multimethod
matrix (MTMM) [13] based on five comparable domains,
including pain, physical mobility, emotional reactions,
energy and social isolation for the NHP and bodily pain,
physical functioning, mental health, vitality and social
functioning for the SF-36 (Table 2). Further, the Mann-
Whitney U-test was used to examine the relative ability of
the two instruments to discriminate among the degrees of
severity of the peripheral vascular disease. Spearman's
rank correlation coefficient was used to express the corre-
lation between quality of life scores, ABPI, type of inter-
vention and age. The internal consistency based on
correlations between items for each scale was assessed
with Cronbach's alpha [36]. The recommended reliability
standard for group-level comparisons is a reliability coef-
ficient of 0.70, while comparisons between individuals
demands a reliability coefficient of 0.90 [25].
The Wilcoxon Signed Ranks test was used to detect the
responsiveness of within-subjects changes over time,
before and one year after revascularization, in patients
with IC and CLI. Data analysis was performed for overall
comparisons using the statistical package SPSS 11.0 and a
P value of <.05 was taken as statistically significant.
Results
Forty-eight (53.3%) patients had IC of whom 26 (54%)
were men. The remaining 42 (46.7%) suffered from CLI
and 22 (52%) of them were men. There was a significant
difference in age between the two groups with a mean age
of 67 and 71 respectively (Table 1). One year postopera-
tively, sixty-six (73%) patients (38 with IC and 28 with
CLI) remained in the study and secondary reconstructions
were made on 7 (10%) patients during the follow-up.
There were no significant differences at baseline in sex,
age, ABPI and quality of life scores between the drop-out
patients and the patients who completed the study. Fur-
ther, there were no significant differences between the
drop-outs and the remaining patients regarding the
method of treatment or severity of ischaemia.
Analyses between the comparable domains showed that
the NHP scores were more skewed than the SF-36 scores,
especially in emotional reactions, energy and social isola-
tion (Figure 1). The "floor effect", the proportion of indi-
viduals having the lowest possible scores (SF-36 = 0, NHP
= 100), was larger for the NHP scale in energy one year
(19.7%) after revascularization than for the SF-36. The
"ceiling effect", the proportion of individuals having the
best possible scores (SF-36 = 100, NHP = 0), was also
larger for the NHP scale in emotional reactions (50.0%),
energy (42.4%) and social isolation (71.2%) one year
after revascularization (Table 3).
Validity
The average convergent validity coefficients exceeded 0.5
one year postoperatively except for physical mobility and
physical functioning (r = -0.46) and for social isolation
and social functioning (r = -0.32), indicating a considera-
ble convergence of the SF-36 and NHP (Table 4). One year
postoperatively significant correlations between ABPI and
physical functioning (r = 0.29) (SF-36), physical mobility
(r = 0.42) and pain (r = 0.42) (NHP) were found. The
severity of the ischaemia had a significant influence in the
Table 2: Comparable domains between the Nottingham Health Profile (NHP) and the Short Form 36 (SF-36) and number of items.
Domains Nottingham Health Profile Short Form 36
Pain Pain (8 items) Bodily pain (2 items)
Physical activity Physical mobility (8 items) Physical functioning (10 items)
Psychological status Emotional reactions (9 items) Energy (3 items) Mental health (5 items) Vitality (4 items)
Social activity Social isolation (5 items) Social functioning (2 items)
Other Sleep General Health Physical role Emotional roleHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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NHP-measured domain of pain (P < .003) and physical
mobility (P < .03), indicating lower quality of life scores
in patients with critical ischaemia. In the ability to dis-
criminate between levels of ischaemia in the other compa-
rable quality of life domains, no significant differences
were found (Table 5).
Internal consistency
Physical functioning (α = 0.82), mental health (α = 0.76)
and vitality (α = 0.70) for the SF-36 and pain (α = 0.71),
emotional reactions (α = 0.76) and energy (α = 0.71) for
the NHP scale were reliable, with coefficients >0.70 before
revascularization. For the SF-36, all of the comparable
domains except for social functioning (α = 0.64) exceeded
the Cronbach's alpha value of 0.8 at the one-year follow-
up. For the NHP the internal consistency coefficient was
less than 0.8 but still exceeded 0.70 (Table 3).
Responsiveness
The NHP scale and SF-36 were not equally good at detect-
ing within-patient changes over time. In patients with IC
the SF-36 scale showed significant improvements in bod-
ily pain (P < .01) and in physical functioning (P < .001)
and for the patients with CLI there were significant
improvements in bodily pain (P < .004) at the one-year
follow-up (Figure 2). The NHP scale showed no signifi-
cant improvements in patients with IC, while in patients
with CLI, significant improvements in pain (P < .001) and
physical mobility (P < .03) were found (Figure 3).
Discussion
The result showed that the SF-36 was less skewed and
more homogeneous with lower "floor" and "ceiling"
effects than the NHP. A considerable convergence in three
of the five comparable domains one year postoperatively
indicates an average convergent validity. The SF-36
Frequency distribution of scores on the NHP (left side) and comparable dimensions on the SF-36 (right side) one year after  revascularization Figure 1
Frequency distribution of scores on the NHP (left side) and comparable dimensions on the SF-36 (right side) one year after 
revascularization. NHP scores had 100 subtracted for consistency with SF-36
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Table 3: Reliability and "floor" and "ceiling" effects in comparable NHP and SF-36 scales before and one year after revascularization.
NHPa Before 
N = 90
% floor % ceiling Alphab values SF-36 Before 
N = 90
% floor % ceiling Alphab values
Pain 5.6 3.3 0.71 Bodily pain 5.6 0 0.57
Physical  
mobility
0 1.1 0.69 Physical 
functioning
2.2 0 0.82
Emotional 
reactions
0 36.7 0.76 Mental health 1.1 3.3 0.76
Energy 27.8 29.9 0.71 Vitality 4.4 0 0.70
Social isolation 0 65.6 0.34 Social 
functioning
0 17.8 0.56
NHPa One 
year n = 66
% floor % ceiling Alphab values SF-36 One 
year n = 66
% floor % ceiling Alphab values
Pain 1.5 13.6 0.76 Bodily pain 1.5 0 0.86
Physical  
mobility
1.5 13.6 0.76 Physical 
functioning
1.5 0 0.87
Emotional 
reactions
1.5 50.0 0.84 Mental health 0 7.6 0.87
Energy 19.7 42.4 0.73 Vitality 4.5 1.5 0.83
Social isolation 3.0 71.2 0.73 Social 
functioning
1.5 34.8 0.64
a The NHP scores are reversed for consistency with the SF-36. b Cronbach's α
Table 4: Multitrait-Multimethod matrix of correlation coefficient for the comparable scales of the SF-36 and NHP in patients with 
varying degrees of lower limb ischaemia one year after revascularization.
SF-36 NHP
Bodily pain Physical 
functioning
Mental 
health
Vitality Social 
functioning
Pain Physical 
mobility
Emotional 
reactions
Energy Social 
isolation
SF-36
Bodily pain -
Physical 
functioning
0.59 -
Mental 
health
0.33 0.43 -
Vitality 0.41 0.48 0.81 -
Social 
functioning
0.35 0.51 0.47 0.45 -
NHP
Pain -0.53 -0.46 -0.12 -0.38 -0.14 -
Physical 
mobility
-0.53 -0.46 -0.12 -0.38 -0.14 1.00 -
Emotional 
reactions
-0.32 -0.39 -0.66 -0.62 -0.38 0.31 0.31 -
Energy -0.45 -0.60 -0.59 -0.65 -0.58 0.43 0.43 0.68 -
Social 
isolation
-0.21 -0.40 -047 -0.40 -0.32 0.03 0.03 0.47 0.47 -
Correlation coefficients for comparable domains of the two questionnaires are shown in bold type Correlation coefficients are negative because 
the two scales run in opposite directions.Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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showed a higher internal consistency except for social
functioning one-year postoperatively and was more
responsive in detecting changes over time in the IC group.
The NHP was more sensitive in discriminating among lev-
els of ischaemia regarding pain and more able to detect
changes in the CLI group.
The attrition or loss of subjects (27%) in this study could
have affected the outcome. Further analysis showed that
there were no significant differences in quality of life, sex,
age, method of treatment and severity of disease between
the attrition group and those who completed the study.
The fact that the NHP and SF-36 differ in their nature and
content may limit the study design. Therefore the analyses
in this study focused only on the comparable domains of
the two instruments, including the basic domains of phys-
ical, mental and social health identified by the WHOQOL
group [7]. A suitable quality of life instrument for patients
with chronic lower limb ischaemia should not only be
valid, reliable and responsive but also simple for elderly
people to understand and complete. In this study there
was no difference in response rate between the two instru-
ments and both seemed to be user-friendly and took
about 5–10 minutes to complete. The findings strengthen
earlier results suggesting that both scales are practical and
acceptable to use in elderly patients [37,38].
A generic quality of life instrument, designed for a variety
of populations and measuring a comprehensive set of
health concepts, is likely to have problems with "ceiling"
and "floor" effects [24]. In this study the NHP showed
higher "ceiling" effects in all dimensions than the SF-36.
There were minor "floor" effects in both the NHP and SF-
36, indicating the lowest possible quality of life. This is in
accordance to Klevsgård et al, [1] who also showed higher
"ceiling" effects in social isolation, emotional reactions
and energy for the NHP than the SF-36. Other studies
have also reported fewer "ceiling" and "floor" effects in
the SF-36 than in the NHP in patients with chronic
obstructive pulmonary disease [39] and after a myocardial
infarction [37]. The advantage of the SF-36 may be due to
its use of a Likert-type response format with a number of
possible different scores and its ability to detect positive as
well negative states of health, whereas the NHP items are
dichotomous and state more extreme ends of ill health
[39]. This could mean that a patient with acceptable initial
scores fails to improve even if the improvement is obvi-
ous. Furthermore, a false negative response will be more
likely when a patient perceives to having perfect function-
ing on a measure that only assesses severe dysfunction.
The result confirms the importance of finding a quality of
life instrument that does have a spectrum of dimensions
which match the patients with chronic lower limb ischae-
mia related to the presence of numerous and often severe
comorbid conditions.
In this study the internal consistency was not as high as
desirable for any of the instruments before revasculariza-
tion, but both instruments exceeded the minimum inter-
nal consistency value of 0.7, except for social functioning
in the SF-36 one year postoperatively. The SF-36, however,
had considerably higher α-values in all other dimensions.
Several studies have previously reported that the SF-36 has
higher Cronbach's α values than the NHP, but the
domains in which the highest and lowest values were
estimated differ [37-40]. The findings suggest that it is not
only the magnitude of the correlation among items, but
also the number of items in the scale that affects the inter-
nal consistency. For example, the domains of pain and
social functioning in the NHP contain 8 and 5 items
Table 5: Differences in comparable domains in the NHP and the SF-36 between claudicants and patients with critical ischaemia before 
revascularization.
Dimension Claudicants n = 48 Critical ischaemia n = 42 P-value
NHP* Md (q1,q3)
Pain 29.9 (27.2–48.5) 54.2 (28.8–84.2) .003
Physical mobility 30.8 (10.3–50.2) 47.3 (20.6–66.7) .03
Emotional reactions 11.4 (0.0–39.3) 10.0 (0.0–25.2) .42
Energy 60.5 (0.0–100) 47.0 (0.0–100) .65
Social isolation 0.0 (0.0–24.2) 0.0 (0.0–25.1) .75
SF-36**Md (q1,q3)
Bodily pain 36.5 (22.0–42.0) 31.0 (22.0–41.0) .27
Physical functioning 25.0 (15.0–40.0) 25.0 (15.0–45.0) .93
Mental health 68.0 (56.0–88.0) 68.0 (51.0–77.0) .54
Vitality 45.0 (31.2–60.0) 45.0 (20.0–60.0) .47
Social functioning 68.7 (50.0–87.5) 62.5 (50.0–78.1) .41
*A higher score (100) indicates more perceived problems. ** A higher score (100) indicates fewer perceived problems. a P-value, claudicants versus 
critical ischaemia patients before revascularization. Tested by Mann-Whitney U-test. p-value = <0.05Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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Changes in median score for the SF-36 in claudicants and critical ischaemia patients before and one year after revascularization Figure 2
Changes in median score for the SF-36 in claudicants and critical ischaemia patients before and one year after revascularization. 
Tested by Wilcoxon Signed Ranks test. A higher score indicates fewer perceived problems. BP = Bodily pain, PF = Physical 
functioning, MH = Mental health, VT = Vitality and SF = Social functioning.
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0
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Claudicants (n=38) 
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  ** 
Critical ischaemia (n=28) Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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Changes in median score for the NHP in claudicants and critical ischaemia patients before and one year after revascularization Figure 3
Changes in median score for the NHP in claudicants and critical ischaemia patients before and one year after revascularization. 
Tested by Wilcoxon Signed Ranks test. A higher score indicates more perceived problems. P = Pain, PM = Physical mobility, 
EM = Emotional reactions, E = Energy and SO = Social isolation.
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Critical ischaemia (n=28) Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/9
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respectively, while bodily pain and social functioning in
the SF-36 contain only 2 items. This is further
strengthened by the fact that both the scales were not sen-
sitive enough to identify significant within-patients
changes in social isolation and social functioning.
Another explanation could be that the patients were a
more homogeneous group before treatment, with similar
problems which affected the quality of life, but one year
postoperatively they have become more heterogeneous
and represent different states of recovery [13]. Both instru-
ments meet the reliability standards for group-level appli-
cation in most respects, although none of them achieved
the degree of reliability that be would be desirable in indi-
vidual-based assessment.
The result in this study showed significant convergent cor-
relation coefficients between scores of the comparable
dimensions except for physical activity and social activity,
indicating a considerable convergence of the NHP and SF-
36 scale. Prieto et al [39] and Meyer-Rosberg et al [40]
demonstrated similar results with an average convergent
validity. Thus the NHP and SF-36 are relatively equal in
the validity and corroborate that the subscales probably
reflect similar impacts of chronic lower limb ischaemia.
However, social isolation in the NHP showed a higher
correlation with mental health in the SF-36 and might
measure more psychological aspects of social life, whilst
social functioning in the SF-36 tends to assess social activ-
ities according to the higher correlation with energy in
NHP. Similarly the physical functioning in the SF-36
showed a higher correlation with energy and may reflect
physical activities of daily living rather than physical
mobility. This suggests that the SF-36 and NHP measure
different aspects of physical and social activities.
Validity in terms of the instruments' relative ability to dis-
criminate among different levels of the ischaemia could
only demonstrate that patients with CLI had significantly
more problems with pain and physical mobility before
treatment than patients with IC measured by the NHP.
Klevsgård et al [1] showed similar results, that the NHP
was more sensitive in discriminating deterioration in pain
and physical mobility than the SF-36. In contrast, Brown
et al [37] demonstrated that the SF-36 was more sensitive
than the NHP for identifying people still troubled with
angina or breathlessness after a myocardial infarction.
Despite the lack of significant differences between
patients with IC and patients with CLI, the NHP scale
tends to be more sensitive in explaining the quality of life
in this group of patients with regard to the dimension of
pain and physical mobility. The important issue thus is to
consider how well the measurement method explains
health-related phenomena which are significant for the
particular targeted disease or group of patients.
The SF-36 was the more responsive instrument in detect-
ing changes in quality of life over time in patients with IC,
including bodily pain and physical functioning one year
postoperatively. However, in patients with CLI, the NHP
was the more responsive instrument, with significant
changes in pain and physical mobility, while the SF-36
showed a significant change only in bodily pain. Falcoz et
al [38] also demonstrated that the SF-36 was more respon-
sive than the NHP in detecting changes five weeks after
cardiac surgery. In contrast, Klevsgård et al [1] showed
that the NHP was more responsive in patients with
chronic lower limb ischaemia one month after revascular-
ization. The result of the present study supports the Trans-
Atlantic Inter-Society Consensus (TASC) [12]
recommendation that SF-36 should be used as a generic
health outcome measure in patients with chronic lower
limb ischaemia. It seems to be more sensitive for detecting
changes in quality of life than the NHP in patients with
IC. In the group of CLI patients who have more problems
with mobility and pain, however, it is harder to evaluate
whether the one questionnaire is superior to the other, the
NHP could be a preferable instrument in this group of
patients.
Conclusion
The findings indicate that both the SF-36 and the NHP
have acceptable degrees of reliability for group-level
comparisons, convergent and construct validity one year
after revascularization. Nevertheless, the SF-36 seems gen-
erally to have more superior psychometric properties and
was more suitable than the NHP for evaluating quality of
life in patients with intermittent claudication. The NHP,
however, discriminated better among severity of ischae-
mia and was more responsive in detecting changes over
time in patients with critical leg ischaemia.
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